| Src-dependent DBL family members drive resistance to vemurafenib in human melanoma CR Feddersen, JL Schillo, A Varzavand, HR Vaughn, LS Wadsworth, ... Cancer research 79 (19), 5074-5087, 2019 | 20 | 2019 |
| Abstract A026: Identifying mechanisms to target in combination with trametinib to improve therapeutic efficacy in low-grade serous ovarian cancer RM Peplinski, SP Nobre, JL Schillo, KK Ulmer, YA Lyons, JD Riordan, ... Cancer Research 84 (5_Supplement_2), A026-A026, 2024 | | 2024 |
| Identifying mechanisms to target in combination with trametinib to improve therapeutic efficacy in low-grade serous ovarian cancer RM Peplinski, SP Nobre, JL Schillo, KK Ulmer, YA Lyons, JD Riordan, ... CANCER RESEARCH 84 (5), 2024 | | 2024 |
| Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance JL Schillo, CR Feddersen, RM Peplinski, LS Powell, A Varzavand, ... NAR cancer 6 (1), zcad061, 2024 | | 2024 |
| Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma EY Zhu, JL Schillo, SD Murray, JD Riordan, AJ Dupuy Iscience 26 (10), 2023 | | 2023 |
| Identifying mechanisms of therapeutic resistance in low-grade serous ovarian cancer (2282) SP Nobre, R Peplinski, J Schillo, K Ulmer, J Riordan, A Dupuy Gynecologic oncology 176, S305, 2023 | | 2023 |
| Characterization of genetic mechanisms of ovarian tumor progression using sleeping beauty mutagenesis in vivo (2296) R Peplinski, J Schillo, K Ulmer, SP Nobre, J Riordan, A Dupuy Gynecologic oncology 176, S313, 2023 | | 2023 |
| Genetic characterization of therapeutic resistance in cutaneous melanoma J Schillo The University of Iowa, 2022 | | 2022 |
| Sleeping Beauty mutagenesis reveals a Src-dependent DBL GEF family signaling mechanism driving MAPK inhibitor resistance in BRAF mutant melanoma. CR Feddersen, J Schillo, A Varzavand, H Vaughn, A Voight, E Zhu, ... CANCER RESEARCH 80 (19), 46-46, 2020 | | 2020 |
| Identification and characterization of Rho family GTPases as drivers of drug resistance in BRAF (V600) mutant melanoma. JL Schillo, CR Feddersen, A Varzavand, HR Vaughn, LS Wadsworth, ... CANCER RESEARCH 80 (19), 48-48, 2020 | | 2020 |
| Abstract B08: Identification and characterization of Rho family GTPases as drivers of drug resistance in BRAFV600 mutant melanoma JL Schillo, CR Feddersen, A Varzavand, HR Vaughn, LS Wadsworth, ... Cancer Research 80 (19_Supplement), B08-B08, 2020 | | 2020 |
| Abstract PR17: Sleeping Beauty mutagenesis reveals a Src-dependent DBL GEF family signaling mechanism driving MAPK inhibitor resistance in BRAF mutant melanoma CR Feddersen, J Schillo, A Varzavand, H Vaughn, A Voight, E Zhu, ... Cancer Research 80 (19_Supplement), PR17-PR17, 2020 | | 2020 |
| Abstract LB-096: A gain-of-function screen identifies drivers of drug resistance in BRAFV600E melanoma cell lines CR Feddersen, JL Schillo, HR Vaughn, AP Voigt, EY Zhu, LS Wadsworth, ... Cancer Research 78 (13_Supplement), LB-096-LB-096, 2018 | | 2018 |
Jesse RiordanUniversity of IowaVerified email at uiowa.edu
Jesse RiordanUniversity of IowaVerified email at uiowa.edu